Tetrahydropalmatine
(THP) has analgesic, hypnotic, sedative, and
other pharmacological effects. Brain-derived neurotrophic factor (BDNF)
plays an important role in neuronal plasticity, growth, and development.
However, their mechanism of action in methamphetamine (MA)-induced
neurotoxicity remains unclear. This study aims to explore the important
role of BDNF in MA neurotoxicity and whether THP can regulate BDNF
through the interaction between tyrosine kinase receptor B (TrkB)/calmodulin
(CAM) to alleviate the neurotoxicity induced by MA. SD rats were randomly
divided into control, MA, and MA + THP groups. Stereotyped behavior
test, captive rejection test, open field test (OFT), and Morris water
maze (MWM) were used to evaluate the anxiety, aggression, cognition,
learning, and memory. Extracted hippocampus and mesencephalon tissue
were detected by Western blot, HE staining, and immunohistochemistry.
TUNEL staining was used to detect apoptosis. MOE was used for bioinformatics
prediction, and coimmunoprecipitation was used to confirm protein
interactions. Long-term abuse of MA resulted in lower weight gain
ratio and nerve cell damage and caused various neurotoxicity-related
behavioral abnormalities: anxiety, aggression, cognitive motor disorders,
and learning and memory disorders. MA-induced neurotoxicity is related
to the down-regulation of BDNF and apoptosis. THP attenuated the MA-induced
neurotoxicity by decreasing CAM, increasing TrkB, phosphorylating
Akt, up-regulating NF-κB and BDNF, and inhibiting cell apoptosis.
MA can induce neurotoxicity in rats. BDNF may play a vital role in
MA-induced neurotoxicity. THP regulates BDNF through TrkB/CAM interaction
to alleviate the neurotoxicity induced by MA. THP may be a potential
therapeutic drug for the neurotoxic and neurodegenerative diseases
related to MA.